Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-29

Clinical Trial Update: Age Differences in Influenza and Herpes Zoster Vaccine Responses (INFLUENZA-SHINGRIX) [Phase 2]

View source ↗

Summary

A Phase 2 trial examining age-related differences in immune responses to influenza and herpes zoster vaccines (INFLUENZA-SHINGRIX) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Radboud University Medical Center | Conditions: Influenza, Herpes Zoster | Phase 2 | Status: COMPLETED